| SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression. | SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
He Y, Wang Y, Luo Z, Zhang X, Bai H, Wang J. | 06/21/2024 |
| Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease. | Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease.
Pan B, Teng Y, Wang R, Chen D, Chen H., Free PMC Article | 06/11/2024 |
| MicroRNA-409-3p/BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice. | MicroRNA-409-3p/BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice.
Bestepe F, Ghanem GF, Fritsche CM, Weston J, Sahay S, Mauro AK, Sahu P, Tas SM, Ruemmele B, Persing S, Good ME, Chatterjee A, Huggins GS, Salehi P, Icli B. | 02/13/2024 |
| miR-103-3p Regulates the Proliferation and Differentiation of C2C12 Myoblasts by Targeting BTG2. | miR-103-3p Regulates the Proliferation and Differentiation of C2C12 Myoblasts by Targeting BTG2.
He Y, Yang P, Yuan T, Zhang L, Yang G, Jin J, Yu T., Free PMC Article | 11/1/2023 |
| Mir-25 Promotes Metastasis of Esophageal Cancer by Targeting BTG2. | Mir-25 Promotes Metastasis of Esophageal Cancer by Targeting BTG2.
Guo B, Tian Z. | 08/30/2023 |
| BTG2 acts as an inducer of muscle stem cell senescence. | BTG2 acts as an inducer of muscle stem cell senescence.
Peng B, Chen Y, Wang Y, Fu Y, Zeng X, Zhou H, Abulaiti Z, Wang S, Zhang H. | 06/16/2023 |
| BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma. | BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
Song J, Xu F, An L, Yin Y, Liu J, Chai J, Yang Y, Li M, Jia Q, Wang Z. | 06/16/2023 |
| LncRNA CARMN inhibits cervical cancer cell growth via the miR-92a-3p/BTG2/Wnt/beta-catenin axis. | LncRNA CARMN inhibits cervical cancer cell growth via the miR-92a-3p/BTG2/Wnt/β-catenin axis.
Wang L, Zhao H, Fang Y, Yuan B, Guo Y, Wang W. | 01/11/2023 |
| Emerging role of anti-proliferative protein BTG1 and BTG2. | Emerging role of anti-proliferative protein BTG1 and BTG2.
Kim SH, Jung IR, Hwang SS., Free PMC Article | 09/3/2022 |
| Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking. | Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking.
Ameerul A, Almasmoum H, Pavanello L, Dominguez C, Winkler GS. | 07/16/2022 |
| Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma. | Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C, Sun Q, Zhang X, Qin N, Pu Z, Gu Y, Yan C, Zhu M, Dai J, Wang C, Li N, Jin G, Ma H, Hu Z, Zhang E, Tan F, Shen H., Free PMC Article | 07/16/2022 |
| Elevated BTG2 improves the radiosensitivity of non-small cell lung cancer (NSCLC) through apoptosis. | Elevated BTG2 improves the radiosensitivity of non-small cell lung cancer (NSCLC) through apoptosis.
Zhu C, Zhang S, Xue A, Feng G, Fan S., Free PMC Article | 05/21/2022 |
| The miR-146b-5p promotes Ewing's sarcoma cells progression via suppressing the expression of BTG2. | The miR-146b-5p promotes Ewing's sarcoma cells progression via suppressing the expression of BTG2.
Qu L, Zhang W, Li J, Liu P., Free PMC Article | 04/16/2022 |
| MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2. | MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2.
Li B, Liu X, Wu G, Liu J, Cai S, Wang F, Yang C, Liu J., Free PMC Article | 02/19/2022 |
| Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis. | Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Lin S, Wang L, Shi Z, Zhu A, Zhang G, Hong Z, Cheng C., Free PMC Article | 02/19/2022 |
| Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis. | Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
Li DY, Lin FF, Li GP, Zeng FC. | 02/19/2022 |
| LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2. | LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2.
Li S, Han Y, Liang X, Zhao M. | 01/8/2022 |
| Integrated Analysis of Prognostic Genes Associated With Ischemia-Reperfusion Injury in Renal Transplantation. | Integrated Analysis of Prognostic Genes Associated With Ischemia-Reperfusion Injury in Renal Transplantation.
Zhang D, Wang Y, Zeng S, Zhang M, Zhang X, Wang Y, Zhang Z, Wang X, Hu X., Free PMC Article | 12/18/2021 |
| MicroRNA miR-92a-3p regulates breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2). | MicroRNA miR-92a-3p regulates breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2).
Jinghua H, Qinghua Z, Chenchen C, Lili C, Xiao X, Yunfei W, Zhengzhe A, Changxiu L, Hui H., Free PMC Article | 12/4/2021 |
| Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells. | Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
Zubair H, Lim IK, Safi SZ, Rehman F, Imran M. | 06/12/2021 |
| SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. | SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
Lv X, Yu H, Zhang Q, Huang Q, Hong X, Yu T, Lan H, Mei C, Zhang W, Luo H, Pang P, Shan H., Free PMC Article | 05/15/2021 |
| NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling. | NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
Xu Z, Wang Y, Xiong J, Cui F, Wang L, Peng H. | 02/6/2021 |
| Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression. | Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression.
Chen Z, Chen X, Lu B, Gu Y, Chen Q, Lei T, Nie F, Gu J, Huang J, Wei C, Sun M, Wang Z., Free PMC Article | 02/2/2021 |
| TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. | TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y, Ma Z, Liu W, Yu T, Yan C, Jiang H, Tian S, Xu T, Shu Y., Free PMC Article | 01/16/2021 |
| miR-487a performs oncogenic functions in osteosarcoma by targeting BTG2 mRNA. | miR-487a performs oncogenic functions in osteosarcoma by targeting BTG2 mRNA.
Gu Z, Wu S, Xu G, Wu W, Mao B, Zhao S. | 01/9/2021 |